Clinical trial
Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or…
NCT00436410 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00436410 |
|---|---|
| Title | Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer |
| Official title | An Evaluation of the Tissue Distribution and the Selective Tumor Trafficking of TNF-Bound Colloidal Gold (CYT-6091) Following Intravenous Administration in Subjects With Primary and Metastatic Cancer Undergoing Surgical Resection |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Early Phase 1 |
| Study type | Interventional |
| Conditions | Adrenocortical Carcinoma, Breast Cancer, Colorectal Cancer, Gastrointestinal Cancer, Kidney Cancer, Liver Cancer, Melanoma (Skin), Ovarian Cancer, Pancreatic Cancer, Sarcoma |
| Intervention type | Biological, Other, Procedure |
| Interventions | colloidal gold-bound tumor necrosis factor, electron microscopy, pharmacological study, conventional surgery |
| Enrollment | 108 |
| Start date | Dec 1, 2006 |
| Completion | Aug 1, 2009 |
| First posted | Feb 19, 2007 |
| Last update posted | May 2, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: